Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

PINK1 p.Leu347Pro mutations in Malays: Prevalence and illustrative cases

Ai Huey Tan, Katja Lohmann, Yi Wen Tay, Jia Lun Lim, Azlina Ahmad-Annuar, Norlisah Ramli, Yen Theng Chin, Ahmad Shahir Mawardi, Khairul Azmi, Zariah Abdul Aziz, Santhi Datuk Puvanarajah, Peter Bauer, Christine Klein, Arndt Rolfs, Shen Yang Lim*

*Korrespondierende/r Autor/-in für diese Arbeit

Abstract

Background: An improved understanding of the genetic determinants of Parkinson's disease (PD) in underrepresented populations, and better characterization of genotype-phenotype correlations in monogenic PD, are needed. Scarce literature exists regarding the genetic aetiology of PD in Malays, who comprise 200 million individuals in South-East Asia. Phenotypic data regarding PARK-PINK1 are also limited. Methods: A multi-ethnic cohort of PD patients from Malaysia (n = 499, including 185 Malays) were tested using a next-generation sequencing-based PD gene panel. The prevalence and clinico-radiological features of patients with the PINK1 p. Leu347Pro mutation are described. This mutation has previously only been reported in people of Filipino or Chamorro (native Guamanian) ancestry. Results: Homozygous p. Leu347Pro mutations were found in five unrelated Malay patients, yielding a prevalence of 6.9% among Malays with PD onset ≤50 years (2.7% of the Malay group overall). This variant was not detected in the homozygous state in 300 Malay controls, but two were heterozygous carriers (0.67%) indicating a relatively high population frequency in keeping with the high frequency of PARK-PINK1 among Malay patients. Interesting clinical features were observed, e.g., differences in the age at PD onset and clinical progression, despite having the same point mutations. Previously unreported brain MRI abnormalities involving the corticospinal tract and hypothalamus, and “loss of the swallow tail” sign, were documented. Conclusions: This report contributes to the very limited literature on PD genetics in the Malay population, and more broadly to the epidemiological, phenotypic and neuroimaging characterization of PARK-PINK1. It also further supports the pathogenicity of the p. Leu347Pro variant.

OriginalspracheEnglisch
ZeitschriftParkinsonism and Related Disorders
Jahrgang79
Seiten (von - bis)34-39
Seitenumfang6
ISSN1353-8020
DOIs
PublikationsstatusVeröffentlicht - 10.2020

Fördermittel

AHT and SYL are supported by the University of Malaya Parkinson's Disease and Movement Disorder Research Program (PV035-2017). KL and CK are supported by the DFG (FOR2488). AAA is supported by a grant from the Ministry of Education Malaysia (FRGS/1/2018/SKK08/ UM /02/3). The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: SYL, KL and CK have received honoraria from the Global Parkinson's Genetics Project (GP2) funded by the Michael J. Fox Foundation (MJFF) and the Aligning Science Across Parkinson's (ASAP) initiative. PB is an employee, and AR the founder and CEO, of Centogene AG. The other authors (AHT, YWT, JLL, AAA, NR, YTC, ASM, KA, ZAA, and SDP) have no conflict of interest.

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen
  2. SDG 5 – Gender Equality
    SDG 5 – Gender Equality
  3. SDG 10 – Weniger Ungleichheiten
    SDG 10 – Weniger Ungleichheiten

Strategische Forschungsbereiche und Zentren

  • Querschnittsbereich: Medizinische Genetik

Fingerprint

Untersuchen Sie die Forschungsthemen von „PINK1 p.Leu347Pro mutations in Malays: Prevalence and illustrative cases“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren